Nanologica AB (4YD) Stock Statistics & Valuation Metrics

Nanologica AB has a market cap or net worth of €8.42M. The enterprise value is €93.32M.

Nanologica AB has 88,357,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nanologica AB’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -47.40%.

The current PE Ratio of Nanologica AB is -1.37. Nanologica AB’s PEG ratio is 0.04.

In the last 12 months, Nanologica AB had revenue of 14.54M and earned -65.63M in profits. Earnings per share was -1.32.

In the last 12 months, operating cash flow was -89.91M and capital expenditures -45.00K, giving a free cash flow of -90.17M billion.

Nanologica AB pays an annual dividend of ―, resulting in a dividend yield of ―

Nanologica AB upcoming earnings date is Jul 11, 2025, TBA Not Confirmed.

Nanologica AB as a current ratio of 1.65, with Debt / Equity ratio of 11.33%

In the past 12 months, Nanologica AB has paid 35.00K in taxes.

Nanologica AB EV to EBITDA ratio is -2.05, with an EV/FCF ratio of -1.14.

Nanologica AB has €28.35M in cash and marketable securities with kr7.24M in debt, giving a net cash position of -€21.10M billion.

Gross margin is 3.04%, with operating margin of -407.59%, and net profit margin of -451.43%.

The average price target for Nanologica AB is ―, which is 11.43% higher than the current price. The consensus rating is ―